tiprankstipranks
Trending News
More News >

Andrew Koven Insider Profile

4 Followers
Andrew Koven, President & Chief Business Off at Aralez Pharmaceuticals, holds 45.70K shares in MetaVia (Ticker: MTVA), holds 16.97K shares in KALA BIO (Ticker: KALA), holds 1.18M shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
tipranks
Andrew Koven

Andrew Koven
Aralez Pharmaceuticals (ARLZQ)
President & Chief Business Off

Ranked #46,094 out of 106,131 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+13.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$79K
92.63%
7.37%
A breakdown of Andrew Koven's holdings

Insider Roles

MetaVia
(MTVA)
Director
KALA BIO
(KALA)
Director
Roles that Andrew Koven holds in companies

Most Profitable Insider Trade

Stock:
Aralez Pharmaceuticals
(ARLZQ)
Rating:Informative Sell
Date:Jun 06, 2017 - Jun 06, 2018
Return:+69.50%
The most profitable trade made by Andrew Koven

Andrew Koven's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ARLZQ
Aralez Pharmaceuticals
Jun 06, 2018
Uninformative Sell
57.93K
$2.37K
KALA BIO
Jun 17, 2025
Director
Uninformative Buy
$5.86K
MetaVia
Jul 01, 2025
Director
Uninformative Buy
$73.58K
AUXL
Auxilium
Jan 30, 2015
Uninformative Sell
1.41M
List of latest transactions for each holding click on a transaction to see Andrew Koven's performance on stock

Andrew Koven insider profile FAQ

What is the percentage of profitable transactions made by Andrew Koven?
The percentage of profitable transactions made by Andrew Koven is 50%.
    What is the average return per transaction made by Andrew Koven?
    The average return per transaction made by Andrew Koven is 13.20%.
      What stocks does Andrew Koven hold?
      Andrew Koven holds: ARLZQ, KALA, MTVA, AUXL stocks.
        What was Andrew Koven’s latest transaction?
        Andrew Koven latest transaction was an Uninformative Buy of ―.
          What was Andrew Koven's most profitable transaction?
          Andrew Koven’s most profitable transaction was an Informative Sell of ARLZQ stock on June 6, 2017. The return on the trade was 69.50%.
            What is Andrew Koven's role in Aralez Pharmaceuticals?
            Andrew Koven's role in Aralez Pharmaceuticals is President & Chief Business Off.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.